Gabapentin and Palladone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabapentin (gabapentin) and Palladone (hydromorphone hydrochloride). Common drug interactions include impaired work ability among females and drug dependence among males.

The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Palladone. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,990 Gabapentin users. Check the latest studies of Gabapentin.

What is Palladone?

Palladone has active ingredients of hydromorphone hydrochloride. eHealthMe is studying from 2,546 Palladone users. Check the latest studies of Palladone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

28 people who take Gabapentin and Palladone together, and have interactions are studied.

Gabapentin and Palladone drug interactions.

What are the common drug interactions of Gabapentin and Palladone, by gender? *:

female:

  1. Impaired work ability
  2. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  3. Nerve injury
  4. Pancreatic enzyme abnormality
  5. Peroneal nerve palsy
  6. Surgery
  7. Walking disability
  8. Weight bearing difficulty (difficulty due to weight of thigh fat deposition)
  9. Activities of daily living impaired
  10. Application site erythema (redness of the skin at application site)

male:

  1. Drug dependence
  2. Emotional distress
  3. Acute abdomen
  4. Adrenal mass
  5. Angina pectoris (chest pain due to ischemia of the heart muscle)
  6. Aortic arteriosclerosis (hardening of the aortic arteries)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Cerebral arteriosclerosis (thickening and hardening of the walls of the arteries in the brain)
  9. Confusional state
  10. Death

What are the common drug interactions of Gabapentin and Palladone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Overdose
  2. Anxiety
  3. Depression
  4. Drug dependence
  5. Emotional distress
  6. Pulmonary oedema (fluid accumulation in the lungs)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Activities of daily living impaired
  9. Application site erythema (redness of the skin at application site)
  10. Application site hyperaesthesia (abnormal increase in sensitivity to stimuli of the sense at application site)

40-49:

  1. Middle ear inflammation (infection of middle ear with pain and swelling)
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Overdose
  4. Pyrexia (fever)
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Deafness unilateral
  7. Drug dependence
  8. Hypersensitivity
  9. Hypertensive heart disease
  10. Infection

50-59:

n/a

60+:

  1. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  2. Emotional distress
  3. Angina pectoris (chest pain due to ischemia of the heart muscle)
  4. Aortic arteriosclerosis (hardening of the aortic arteries)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Cerebral arteriosclerosis (thickening and hardening of the walls of the arteries in the brain)
  7. Death
  8. Dehydration (dryness resulting from the removal of water)
  9. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  10. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)

What are the existing conditions these people have? *

  1. Pain: 12 people, 42.86%
  2. Constipation: 4 people, 14.29%
  3. Cancer Pain: 4 people, 14.29%
  4. Nausea (feeling of having an urge to vomit): 3 people, 10.71%
  5. Sleep Disorder: 2 people, 7.14%
  6. Retching (strong involuntary effort to vomit): 2 people, 7.14%
  7. Panic Disorder: 2 people, 7.14%
  8. Multiple Myeloma (cancer of the plasma cells): 2 people, 7.14%
  9. Lung Cancer - Non-Small Cell (lung cancer): 2 people, 7.14%
  10. High Blood Pressure: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Palladone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gabapentin and Palladone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Palladone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Palladone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on gabapentin and hydromorphone hydrochloride (the active ingredients of Gabapentin and Palladone, respectively), and Gabapentin and Palladone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: